Avasimibe
-
Catalog number9506-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate; CI-1011; PD 148515
-
DescriptionAvasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe also inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (IC₅₀ = 26.5 µM).
-
CAS Number166518-60-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₉H₄₃NO₄S
-
Molecular Weight501.72
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>35 mg/ml)
-
HandlingProtect from air and light
-
Tag LineAn acyl coenzyme A: cholesterol acyltransferase (ACAT) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00934956
-
PubChem CID166558
-
SMILESCC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
-
InChiInChI=1S/C29H43NO4S/c1-17(2)22-14-25(20(7)8)27(26(15-22)21(9)10)16-28(31)30-35(32,33)34-29-23(18(3)4)12-11-13-24(29)19(5)6/h11-15,17-21H,16H2,1-10H3,(H,30,31)
-
InChi KeyPTQXTEKSNBVPQJ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameAvasimibe
-
Alternative nameAvasimibe
-